CARMEL, Ind., Dec. 01, 2025 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis” or the “Company”) (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies for chronic and debilitating conditions in children and adults, today announced that it has been awarded a Veterans Affairs (VA) Federal Supply Schedule (FSS) contract, effective December 1, 2025. The first product listed on the FSS is the IB-Stim®, a drug-free treatment for functional abdominal pain in patients 8 years and ...

MONTREAL, Dec. 01, 2025 (GLOBE NEWSWIRE) -- Brunswick Exploration Inc. (TSX-V: BRW, OTCQB: BRWXF; “BRW” or the “Company”) is pleased to announce more results from its inaugural drilling campaign at the Anatacau Main Project, located in the Eeyou Istchee-James Bay region of Quebec. All results have now been received and cement BRW’s latest discovery within its growing portfolio as a high priority target for follow-up drilling. Highlights include: 1.53% Li2O over 53.9 meters in drill hole AN-25-04 at a verti ...

Highlights: Four (4) drill holes from the 2025 infill drill program with strong analytical results are reported herein: CS25-040: 12 separate intervals, including 95.1 metres (“m”) at 1.56% Li2O, 81.9 m at 1.56% Li2O and 66.5 m at 1.26% Li2O;CS25-041: seven (7) separate intervals, including 53 .9 m at 1.53% Li2O, 54.0 m at 1.21% Li2O and 41.2 m at 1.31% Li2O;CS25-042: 16 separate intervals, including 32.7 m at 1.56% Li2O, 26.5 m at 1.53% Li2O, 26.3 m at 1.47% Li2O, 32.1 m at 1.14% Li2O, and 26.1 m at 1.13% ...

Press Release 01 December 2025 Signify completes share repurchase program Eindhoven, the Netherlands – Signify (Euronext: LIGHT), the world leader in lighting, today announced that it has completed its share repurchase program for 2025. Signify repurchased a total of 7,108,671 shares for a total consideration of EUR 150m million from February 4, 2025 until November 28, 2025. These repurchases were made as part of the company’s repurchase program which was announced on February 4, 2025. Signify will use 1,3 ...

BURLINGTON, Mass., Dec. 01, 2025 (GLOBE NEWSWIRE) -- Fractyl Health, Inc. (Nasdaq: GUTS) (the Company or Fractyl), a metabolic therapeutics company focused on pattern-breaking approaches that treat root causes of obesity and type 2 diabetes (T2D), today announced that Harith Rajagopalan, M.D., Ph.D., Co-Founder and Chief Executive Officer of the Company, will be participating in a fireside chat at the 8th Annual Evercore Healthcare Conference, being held December 2-4, 2025, in Coral Gables, FL. 8th Annual E ...

TORONTO, Dec. 01, 2025 (GLOBE NEWSWIRE) -- Emerita Resources Corp. (TSX-V: EMO; OTCQB: EMOTF; FSE: LLJA) (the “Company” or “Emerita”) announces a 1,536km Helicopter time-domain electromagnetic and magnetic (HTEM) aerial geophysical survey over the Iberian Belt West (IBW) project and the adjacent San Antonio exploration project to commence in December 2025. The survey will cover the existing IBW deposits (La Romanera, El Cura and La Infanta) which will provide signatures to prioritize anomalies associated wi ...

LONDON, Dec. 01, 2025 (GLOBE NEWSWIRE) -- Marex Group plc (‘Marex’ or the ‘Group’; NASDAQ: MRX), the diversified global financial services platform, today announces that it has completed the acquisition of UK equity market maker Winterflood Securities (“Winterflood”). Marex further announces it has entered into a conditional agreement to sell Winterflood’s custody business, Winterflood Business Services (“WBS”), to Epiris Fund III, advised by Epiris LLP (“Epiris”), a UK private equity firm. WBS provides out ...

SAN FRANCISCO, Dec. 01, 2025 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted protein degradation medicines in oncology and autoimmune diseases, today announced that the company will host a live webcast on Monday, December 8, 2025, at 8:15 p.m. ET, to review new and updated clinical data from the ongoing Phase 1a/1b clinical trial of its Bruton’s tyrosine kinase (BTK) degrader progr ...

NEW YORK, Dec. 01, 2025 (GLOBE NEWSWIRE) -- Syndax Pharmaceuticals (Nasdaq: SNDX), a commercial-stage biopharmaceutical company advancing innovative cancer therapies, today announced that Michael A. Metzger, Chief Executive Officer, will participate in a fireside chat at the 8th Annual Evercore Healthcare Conference on Thursday, December 4, 2025, at 11:15 a.m. ET. A live webcast of the fireside chat will be available in the Investor section of the Company's website at www.syndax.com, where a replay will als ...

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES MONTRÉAL, Dec. 01, 2025 (GLOBE NEWSWIRE) -- NioBay Metals Inc. (TSX-V: NBY) (“NioBay” or the “Corporation”), is pleased to announced that it has entered into an agreement with Red Cloud Securities Inc. (“Red Cloud”) to act as sole agent and bookrunner in connection with a “best efforts” private placement (the “Marketed Offering”) for aggregate gross proceeds of up to C$5,000,000 from the sale of any combinatio ...